secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANGOCEUTICALS, INC. (MGRX)
CIK:        0001938046
Form:       8-K
Filed at:   2025-01-15T23:59:59+00:00
Accession:  0001493152-25-002389
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mangoceuticals subsidiary creates Series A Preferred Stock granting CEO 51% voting control
--------------------------------------------------------------------------------

- Series A Preferred Stock of M&P subsidiary gives holders 51% of total vote on all shareholder matters.
- 100 shares designated; expected to be issued to CEO Jacob Cohen under his employment agreement.
- M&P cannot amend charter or issue more shares without 66-2/3% approval of Series A holders.
- Designation filed Jan 9, 2025, effective same date; filed with Texas SOS on Jan 15.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938046/000149315225002389/0001493152-25-002389-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938046/000149315225002389/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-002389

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer